Get the Stockscreener App
514.61
0.79%
-4.10
After Hours:
514.61
Idexx Laboratories Inc stock is traded at $514.61, with a volume of 329.52K.
It is down -0.79% in the last 24 hours and down -1.01% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$518.71
Open:
$523.05
24h Volume:
329.52K
Relative Volume:
0.53
Market Cap:
$41.39B
Revenue:
$3.93B
Net Income/Loss:
$894.97M
P/E Ratio:
47.56
EPS:
10.82
Net Cash Flow:
$837.70M
1W Performance:
-3.52%
1M Performance:
-1.01%
6M Performance:
+22.74%
1Y Performance:
+9.32%
1-Day Range:
$513.25
$523.05
1-Week Range:
$506.91
$535.62
52-Week Range:
$356.14
$549.52
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
514.61 | 42.89B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
414.75 | 164.16B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.05 | 146.60B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
113.99 | 35.02B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
160.63 | 28.16B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
What analysts say about IDEXX Laboratories Inc. stockFree Investment Case Studies - jammulinksnews.com
IDEXX Laboratories Inc. Stock Analysis and ForecastFree Stock Selection - Autocar Professional
What drives IDEXX Laboratories Inc. stock priceExtraordinary performance - Autocar Professional
Is IDEXX Laboratories Inc. a good long term investmentFree Consultation - jammulinksnews.com
How high can IDEXX Laboratories Inc. stock price go in 20253x Return Stock Radar - beatles.ru
Leerink Partners Forecasts Strong Price Appreciation for IDEXX Laboratories (NASDAQ:IDXX) Stock - MarketBeat
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $600 - 富途牛牛
Expert Outlook: IDEXX Laboratories Through The Eyes Of 6 Analysts - 富途牛牛
**IDEXX Laboratories: A High-Quality Business with Strong Fundamentals and Attractive Long-Term Growth Prospects** - AInvest
IDEXX Laboratories, Inc.: A Business With Very Strong Fundamentals (NASDAQ:IDXX) - Seeking Alpha
Idexx Laboratories (IDXX) Sees Raised Price Target from Leerink Analyst | IDXX Stock News - GuruFocus
Here's What to Expect From IDEXX Laboratories' Next Earnings Report - MSN
Are Robust Financials Driving The Recent Rally In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock? - 富途牛牛
Here's What To Expect From IDEXX Laboratories' Next Earnings Report - Barchart.com
IDEXX Laboratories (IDXX) Announces Election of New Independent Director - GuruFocus
IDEXX Laboratories Appoints Joseph L. (Jay) Hooley To Board - citybiz
IDEXX Laboratories Expands Board with New Director - TipRanks
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors - AInvest
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago - Yahoo Finance
IDEXX Laboratories Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - simplywall.st
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years - Benzinga
Stifel Nicolaus Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Idexx Laboratories stock hits 52-week high at $546.61 By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at $546.61 - Investing.com
IDEXX Laboratories (IDXX) Price Target Raised by Stifel | IDXX Stock News - GuruFocus
(PDF) Performance comparison of SNAP® 4Dx® plus and AccuPlex®4 for the detection of antibodies to Borrelia burgdorferi and Anaplasma phagocytophilum - researchgate.net
Stifel Adjusts Price Target on IDEXX Laboratories to $540 From $510, Maintains Hold Rating - MarketScreener
Investing in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Would Have Delivered You a 58% Gain - 富途牛牛
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) dropped from Russell 1000 Dynamic Index - MarketScreener
(PDF) Validation of immune complex dissociation methods for use with heartworm antigen tests - researchgate.net
What Makes IDEXX Laboratories (IDXX) a Good Investment? - Insider Monkey
IDEXX Laboratories to Release 2025 Second Quarter Financial Results | IDXX Stock News - GuruFocus
Idexx Laboratories stock hits 52-week high at $530.74 - Investing.com
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey
12 Best Healthcare Stocks to Buy Now - Insider Monkey
IDEXX Laboratories Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
IDEXX Laboratories (IDXX) Sees Price Target Raised by Leerink Pa - GuruFocus
Three Lawmakers Bought This Biotech Stock Before Supporting A Bill That Could Boost Its Value: It's Now Up 44% - Benzinga
Is IDEXX Laboratories Stock Outperforming The Dow? - Barchart.com
Is IDEXX Laboratories Stock Outperforming the Dow? - The Globe and Mail
Leerink Partners Adjusts IDEXX Laboratories Price Target to $580 From $515 - MarketScreener
Kalkine : IDEXX Laboratories Performance Within S&P 500 Index Framework - Kalkine Media
IDEXX Labs $IDXX Sees Surge in Political Buys: 3 Politicians on Agriculture Committees Invest – Crypto Market Eyes Regulatory Impact - Blockchain News
IDEXX Catalyst Cortisol Rapid Canine Dx - Precedence Research
Amazon Delivery Robots Could Haunt Your Front Porch - Yahoo! Autos
Jim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can’t Get My Arms Around It” - MSN
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders - StreetInsider
IDEXX Laboratories (IDXX) Stock Analysis: A Look at Its Robust 59.33% ROE Amidst Market Challenges - DirectorsTalk Interviews
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):